Ceylan, Selinda; Aeschbacher, Stefanie; Altermatt, Anna; Sinnecker, Tim; Rodondi, Nicolas; Blum, Manuel; Coslovsky, Michael; Evers-Dörpfeld, Simone; Niederberger, Sacha; Conen, David; Osswald, Stefan; Kühne, Michael; Düring, Marco; Wuerfel, Jens; Bonati, Leo (2022). Sex differences of vascular brain lesions in patients with atrial fibrillation. Open Heart, 9(2), e002033. B M J Group 10.1136/openhrt-2022-002033
|
Text
e002033.full.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (808kB) | Preview |
OBJECTIVE
To examine sex differences in prevalence, volume and distribution of vascular brain lesions on MRI among patients with atrial fibrillation (AF).
METHODS
In this cross-sectional analysis, we included 1743 patients with AF (27% women) from the multicentre Swiss Atrial Fibrillation study (SWISS-AF) with available baseline brain MRI. We compared presence and total volume of large non-cortical or cortical infarcts (LNCCIs), small non-cortical infarcts, microbleeds (MB) and white matter hyperintensities (WMH, Fazekas score ≥2 for moderate or severe degree) between men and women with multivariable logistic regression. We generated voxel-based probability maps to assess the anatomical distribution of lesions.
RESULTS
We found no strong evidence for an association of female sex with the prevalence of all ischaemic infarcts (LNCCI and SNCI combined; adjusted OR 0.86, 95% CI 0.67 to 1.09, p=0.22), MB (adjusted OR 0.91, 95% CI 0.68 to 1.21, p=0.52) and moderate or severe WMH (adjusted OR 1.15, 95% CI 0.90 to 1.48, p=0.27). However, total WMH volume was 17% larger among women than men (multivariable adjusted multiplicative effect 1.17, 95% CI 1.01 to 1.35; p=0.04). Lesion probability maps showed a right hemispheric preponderance of ischaemic infarcts in both men and women, while WMH were distributed symmetrically.
CONCLUSION
Women had higher white matter disease burden than men, while volume and prevalence of other lesions did not differ. Our findings highlight the importance of controlling risk factors for cerebral small vessel disease in patients with AF, especially among women.